Editas Medicine Inc
F:8EM
Editas Medicine Inc
F:8EM
Price:
2.42
EUR
-7.28%
Market Closed
Market Cap:
€199m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Editas Medicine Inc
F:8EM
|
US |
|
H
|
Hall of Fame Resort & Entertainment Co
F:7MV0
|
US |
|
B
|
Berliner Effektengesellschaft AG
XMUN:BFV
|
DE |
|
M
|
Medicure Inc
F:NGQ1
|
CA |
|
Inapa Investimentos Participacoes e Gestao SA
F:IPB
|
PT |
|
V
|
Veerkrupa Jewellers Ltd
BSE:543545
|
IN |
|
A
|
Alter Ego Media SA
ATHEX:AEM
|
GR |
|
Sterling Metals Corp
XTSX:SAG
|
CA |
Wall St Price Targets
8EM Price Targets Summary
Editas Medicine Inc
Editas Medicine Inc
Wall Street analysts forecast 8EM stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 8EM is 7.25 EUR with a low forecast of 1.23 EUR and a high forecast of 19.16 EUR.
Lowest Forecast
Price Target
1.23
EUR
49% Downside
Average Forecast
Price Target
7.25
EUR
200% Upside
Highest Forecast
Price Target
19.16
EUR
692% Upside
Editas Medicine Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8EM's stock price target?
Price Target
7.25
EUR
7.25
EUR
According to Wall Street analysts, the average 1-year price target for 8EM is 7.25 EUR with a low forecast of 1.23 EUR and a high forecast of 19.16 EUR.
What is the Revenue forecast for Editas Medicine Inc?
Projected CAGR
21%
21%
The compound annual growth rate for Revenue over the next 8 years is 21%.
